Rheumatoid Arthritis and Lupus Flashcards
Rheumatoid Arthritis (RA)
systemic, autoimmune disease
Type III hypersensitivity
inflammatory disease of synovium
RA: Etiology
not well understood
environmental and genetic factor
-genetic link + triggering event
-inappropriate immune response to joint injury
RA: Other Risk Factors
age: 40’s-60’s
women
tobacco use
family history (genetic link)
RA: Pathogenesis
-immune cells attack synovial tissue
(immune cells: lymphocytes and macrophages)
-produce rheumatoid factor (RF)
-antibody against the body’s own antibodies (IgG)
-formation of immune complexes
RA: A Progressive Disease
-intensifying inflammatory response
-cartilage destroyed by osteoclasts
-pannus develops: inflammation and exuberant proliferation of synovium (hypertrophied synovium)
-pannus leads to:
-bone erosion
-bone cysts
-fissure development
RA: Early CM
very little, maybe joint pain/discomfort
RA: Eventual Joint Manifestations
symmetrical
pain, stiffness, motion limitations
inflammation: heat, swelling, tenderness
RA: Advanced Disease CM
deformity and disability
joint subluxation
RA: Systemic Involvement
fatigue and malaise
potentially affects any and all body systems (depending on severity)
MOST common:
-Sjorgren’s Syndrome
-Rheumatoid Nodules
Sjorgren’s Syndrome
destruction of moisture-producing gland (salivary and lacrimal)
-gritty, dry, itchy eyes
-fissured, dry tongue
Rheumatoid Nodules
immune mediated granulomas; develop around inflamed joints, subcutaneous and firm, sometimes painful
-common sites: around elbow and knuckles
RA: Goals for Pharm
relieve pain and swelling
slow or stop progression of disease
-long-term drug therapy requires pt. adherence
-NSAIDs
-glucocorticoids (short-term)
-disease-modifying anti-rheumatic drugs
-DMARDs slow/stop progression
Corticosteroids in RA
usually prednisone
rapid suppression of inflammation
use ONLY when symptoms NOT controlled with NSAIDs
not best choice for long term therapy
-usually small doses less than 10mg/day (seen as small as 2.5mg)
Systemic Lupus Erythematosus (Lupus): Pathogenesis
B-lymphocytes are hyperactive and produce autoantibodies
-ANA: antinuclear
antibody
Activated against DNA
Formation of: immune COMPLEXES
Can impact all major organ systems!
Inflammatory response destroys tissue
Lupus: Predisposing Factors (8)
genetic factors
gender: female
age: 20-40
race: Black/African Americans higher likelihood
environmental triggers (SUN exposure)
allergy to antibiotics
hormonal factors
tobacco use